Could serotonin explain albinism symptoms?
NCT ID NCT06138509
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study investigates whether serotonin, a chemical in the body, affects symptoms of oculocutaneous albinism in children. Researchers will measure serotonin levels in 160 children with and without albinism. The goal is to better understand the condition, not to test a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could reveal a link between serotonin and albinism symptoms, potentially pointing toward new ways to manage the condition.
- What could go wrong
- This is an observational study, not a treatment trial. It is small and early-stage, so findings may not lead to direct benefits or apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OCULOCUTANEOUS ALBINISM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Necker-Enfants Malades
RECRUITINGParis, 75015, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.